tbuckley/cabot-search huggingface dataset:
Real-World Outcomes Among 2L+ Patients with Chronic Lymphocytic Leukemia (CLL) By Line of Therapy (LOT)
Authors: Matthew S. Davids, Jacob Ambrose, Enrico De Nigris, Jennifer Prescott, Siyang Leng, Mohammed Z.H. Farooqui, Shravanthi R. Gandra, Christina M. Zettler, Laura L. Fernandes, Ching-Kun Wang, Mazyar Shadman
Journal: Blood (2023)
Molecular Monitoring with Tumor DNA and Nivolumab Maintenance: A Pilot Study in Diffuse Large B-Cell Lymphoma
Authors: Shazia Nakhoda, Tamarrah Sklarz, Cheyenne Pagan, Matthew Matasar, Marcus Messmer, Zachary AK Frosch, Y. Lynn Wang, Asya Varshavsky Yanovsky, Rashmi Khanal, Carlyn Rose Tan, Henry C. Fung, Eli Mikkelsen, Kevin A. David, Mark Roschewski, Eric Ross, Allison P. Jacob, Erin Ahn, Nadia Khan
Journal: Blood (2023)
A Matching-Adjusted Indirect Comparison of the Efficacy of Elranatamab Versus Physician's Choice of Treatment in Patients with Triple-Class Exposed/Refractory Multiple Myeloma
Authors: Isha Mol, Yannan Hu, Thomas W LeBlanc, Joseph C Cappelleri, Haitao Chu, Guido Nador, Didem Aydin, Alex Schepart, Patrick Hlavacek
Journal: Blood (2023)
Updated Results from a Matching-Adjusted Indirect Comparison of Efficacy Outcomes of Isatuximab Plus Carfilzomib and Dexamethasone Versus Daratumumab Plus Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma
Authors: Joshua Richter, Peggy L Lin, Viviana Garcia-Horton, Patricia Guyot, Zheng-Yi Zhou, Mark Sievert
Journal: Blood (2023)
Day 100 Risk Assessment Tool Predicts 1 Year Survival in Allogeneic Hematopoietic Cell Transplant Patients
Authors: Joseph Farinella, Lauren M Granat, Hong Li, Sharon M Caroniti, Pranay S. Hegde, Matt Kalaycio, Ronald Sobecks, Claudio Brunstein, Craig S Sauter, Betty K. Hamilton
Journal: Blood (2023)
Clonal Dynamics and Deterministic Clinical Fate Mapping of Patients with Myelodysplastic Neoplasms and Acute Myeloid Leukemia with <i>TP53</i> Disruption
Authors: Shyam Ajay Patel, Benjamin Tanenbaum, Asiri Ediriwickrema, Jan Cerny, Lloyd Hutchinson, Xiuling Meng, William K Gerber, Salwa Khedr, William Selove, Bruce Woda, Jonathan M. Gerber
Journal: Blood (2023)
Secondary Acute Myeloid Leukemia from a Previous Chronic Myeloproliferative Neoplasm: A Study of Grelam-Chile Concerning Chilean Patients on Behalf of AML Pethema Registry
Authors: Marcela Espinoza, Monica Alejandra Romero, Joaquín Jerez, Francisca Bass, Veronica Lizama, Rafael Benavente, Matias Eugenio Sanchez, Natalia Aranguiz, Miguel Nicolas Lopez, Maria Carolina Guerra, Sebastián Hidalgo, Verónica Pérez, Belkys Mercedes Linares, Robert Holloway Melo, Lucas Carcamo, Christine Rojas, Hernán López-Vidal, Juan Manuel Sanchez, Francisco Samaniego, Pau Montesinos, David Martinez-Cuadron
Journal: Blood (2023)
Roginolisib a Highly Selective Allosteric Modulator of the Phosphoinositide 3-Kinase Delta (PI3Kδ) in Patients with Refractory/Relapsed Follicular Lymphoma
Authors: Carmelo Carlo-Stella, Michael Lahn, Tracey Hammett, Paramjit Kaur, Rebeca Zorrilla, Giusy Di Conza, Lars van der Veen, Catherine Pickering, Armando Santoro
Journal: Blood (2023)
Revisiting Ratify: Daunorubicin 60 Mg/m2 Vs 90 Mg/m2 in Previously Untreated <i>FLT3</i>mut Acute Myeloid Leukemia
Authors: Ian Bouligny, Graeme Murray, Thuy Ho, Juhi Gor, Kyle Zacholski, Nolan Wages, Steven Grant, Keri Maher
Journal: Blood (2023)
A Subset of Classical Hodgkin Lymphoma Cases Demonstrate CD19 Expression on Hodgkin Reed-Sternberg Cells By Immunohistochemistry
Authors: Sarah Helman, Fikru Merechi, Hanan Alharthy, Madhurima Koka, Michael Kallen, Aaron P. Rapoport, Jennie Law, Seung Tae Lee, Zeba N Singh
Journal: Blood (2023)
Efficacy Analysis of Ixazomib-Based Regimens Based on Dynamic Frailty Assessment in Elderly and Frail Patients with Newly Diagnosed Multiple Myeloma
Authors: Jianmei Xu, Hua Xue, Songying Zhao, Jing Wang, Huimei Guo, Jiangbo Zhang, Jia Liu, Luoming Hua, Mingjie Tian, Mingfeng Zhao
Journal: Blood (2023)
Zanubrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): Interim Results from a Phase 1b Clinical Trial
Authors: Yazeed Sawalha, Rina Li Welkie, Anna Krivenko, Brian Hess, Audrey M. Sigmund, Timothy Voorhees, Walter Hanel, David A. Bond, John C Reneau, Narendranath Epperla, Lapo Alinari, Jonathan E. Brammer, Beth Christian, Robert Baiocchi, Kami J. Maddocks
Journal: Blood (2023)
Frontline Aspacytarabine with Venetoclax for Older/Unfit Patients with Acute Myeloid Leukemia: Preliminary Results of a Phase 1 Study
Authors: Jessica K. Altman, Yasmin Abaza, Michael Keng, Abhishek Maiti, Jamie Koprivnikar, Shoshi Tessler, Chen Blumberg, Liat Flaishon, Ruth Ben Yakar
Journal: Blood (2023)
CAR-T Cells for Systemic Lupus Erythematosus
Authors: Matteo Doglio, Alessia Ugolini, Clara Bercher, Cristiano Toma, Chiara Bonini, Fabio Ciceri, Barbara Camisa, Rossana Norata, Stefania Del Rosso, Francesca Sanvito, Monica Casucci, Angelo Manfredi
Journal: Blood (2023)
A Phase 2 Study of Isatuximab in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone, Followed By Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients with Multiple Myeloma and Severe Renal Impairment
Authors: Evangelos Terpos, Efstathios Kastritis, Argiris Symeonidis, Anastasia Pouli, Sosana Delimpasi, Eirini Katodritou, Eleftheria Hatzimichael, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Rodanthi Syrigou, Evangelos Eleutherakis-Papaiakovou, Kyriaki Manousou, Maria Gavriatopoulou, Meletios A. Dimopoulos
Journal: Blood (2023)
Responses to Combination Chemotherapy with MAPK Pathway Inhibition in Relapsed and Refractory LCH
Authors: Vivekanudeep Karri, Nader Kim El-Mallawany, Howard Lin, Harshal A Abhyankar, Jennifer Elise Agrusa, Jessica Velazquez, Olive S. Eckstein, Nitya Gulati, Carl E Allen, Kenneth L. McClain
Journal: Blood (2023)
Speckle Tracking Echocardiography for the Diagnosis and Prognosis of Light Chain Cardiac Amyloidosis
Authors: Hongmiao Shen, Chengcheng Fu, Xingyue Wu, Hongying You, Zhi Yan, Weiqin Yao, Jiao Lu, Yingying Zhai, Jing Wang, Xiaolan Shi, Shuang Yan, Jingjing Shang, Song Jin, Lingzhi Yan, De-Pei Wu
Journal: Blood (2023)
Multicenter Open Label Phase 2 Study of Quadruplet-Based Regimen Iskpd (isatuximab plus pomalidomide and dexamethasone with carfilzomib) in Early Relapsed or Refractory Multiple Myeloma - IFM2018-03
Authors: Arthur Bobin, Jerome Lambert, Stéfanie Ragot, Aurore Perrot, Salomon Manier, Lionel Karlin, Denis Caillot, Lotfi Benboubker, Thomas Chalopin, Carla Araujo, Jean Fontan, Thorsten Braun, Clara Mariette, Elodie Scherman, Olivier Decaux, jean Sebastien Blade, Faiza Keddar, Christophe Roul, Mamoun Dib, Jill Corre, Frederique Orsini Piocelle, Laure Vincent, Cyrille Touzeau, Philippe Moreau, Herve Avet Loiseau, Xavier Leleu
Journal: Blood (2023)
Methotrexate in Combination with Orelabrutinib, Thiotepa, and Rituximab (R-MTO) Followed By Autologous Stem-Cell Transplant for Primary Central Nervous System Lymphoma Treatment
Authors: Lijie Xing, Haichen Wei, Dan Liu, Hui Wang, Ping Li, Linna Xie, Zengjun Li
Journal: Blood (2023)
Reduced Intensity Condition of ATG Based Haploidentical Hematopoietic Stem Cell Transplantation in Elderly or Unfit Patients
Authors: Mingyue Pan, Yibo Wu, Luxin Yang, Jimin Shi, Xiaoyu Lai, Lizhen Liu, Yanmin Zhao, Jian Yu, Sun Jie, Weiyan Zheng, Wenjun Wu, Zhen Cai, He Huang, Yi Luo
Journal: Blood (2023)
30-Minute Infusion of Isatuximab in Newly Diagnosed Multiple Myeloma (NDMM) Patients: Results of a Phase 1b Study
Authors: Enrique M Ocio, Aurore Perrot, Philippe Moreau, Maria-Victoria Mateos, Sara Bringhen, Joaquin Martinez-Lopez, Lionel Karlin, Igor Wolfgang Blau, Song-Yau Wang, Maurizio Martelli, Corina Oprea, Yvonne Dong, Ercem Kodas, Jesus San Miguel
Journal: Blood (2023)
Update of Swatch Study: Selinxor Combined with Lenalidomide and Rituximab (R2) in Adults with Diffuse Large B Cell Lymphoma (DLBCL) and Indolent Non-Hodgkin's Lymphoma (iNHL)
Authors: Li Wang, Zhiming Li, Lina Zhang, Liling Zhang, Jay Mei, Wei Li Zhao
Journal: Blood (2023)
First Disclosure of AZD9829, a TOP1i-ADC Targeting CD123: Promising Preclinical Activity in AML Models with Minimal Effect on Healthy Progenitors
Authors: Dipannita Dutta, Pan Pan, Ryan Fleming, Marcio Andrade-Campos, Elena Belova, Jennifer Wheeler, Patricia Cheung, Paul Santacroce, Casey Daniels, Darrin Sabol, Brad Jakubison, Benedicte Recolin, Andrew Dippel, Margaret Wey, Arthur Shaffer, Edward Rosfjord, Elaine Hurt, Gullu Gorgun, Anas Younes, Puja Sapra
Journal: Blood (2023)
Chronic Obstructive Pulmonary Disease and Previous Infections Have Impact on Infectious Complications in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax: A Multicentre Seifem Study
Authors: Francesco Autore, Andrea Visentin, Marina Deodato, Candida Vitale, Eugenio Galli, Alberto Fresa, Rita Fazzi, Alessandro Sanna, Jacopo Olivieri, Ilaria Scortechini, Maria Ilaria Del Principe, Paolo Sportoletti, Luana Schiattone, Nilla Maschio, Davide Facchinelli, Marta Coscia, Alessandra Tedeschi, Livio Trentin, Idanna Innocenti, Anna Candoni, Alessandro Busca, Livio Pagano, Luca Laurenti
Journal: Blood (2023)
Safety and Efficacy of Bortezomib-Pomalidomide-Dexamethasone (VPD) As Novel Induction Therapy in Newly-Diagnosed Multiple Myeloma: Updated Data from an Ongoing Single Arm Phase-II Investigator- Initiated Clinical Trial (PRIME Study)
Authors: Jeevan Kumar, Rajat Pincha, Vivek S Radhakrishnan, Naveed Tamboli, Arijit Nag, Dibakar Podder, Debranjani Chattopadhyay, Saurabh Jayant Bhave, Sreya Das, Mayur Parihar, Asish Rath, Sushant Vinarkar, Sumit Mukhopadhyay, Subhosmito Chakraborty, Deepak Kumar Mishra, Mammen Chandy, Reena Nair
Journal: Blood (2023)
Anti-BCMA Dual Epitope-Binding CAR-Marrow Infiltrating Lymphocytes (MILs) Could Offer a Potent Innovative Immunotherapeutic Tool Against Multiple Myeloma
Authors: Manh-Cuong Vo, Sung-Hoon Jung, Van-Tan Nguyen, Van-Dinh-Huan Tran, Sang-Ki Kim, Woo Kyun Bae, Hyeoung-Joon Kim, Lin Wang, Je-Jung Lee
Journal: Blood (2023)
Application Gene Variation Detection before and after Hematopoietic Stem Cell Transplantation to Predict the Relapse of Hematopoietic Neoplasm Patients after Transplantation: Retrospective Data from a Single Center in China
Authors: Jia Liu, Peiyan Kong, Lidan Zhu, Shichun Gao, Lu Wang, Huanfeng Liu, Ting Chen, Yimei Feng, Yuqing Liu, Lei Gao, Xi Zhang
Journal: Blood (2023)
Mitoxantrone Hydrochloride Liposome, Gemcitabine, Vinorelbine with or without Rituximab (GVM±R) in Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Authors: Wei Liu, Yi Wang, Yan Xu, Chenxing Du, Qi Wang, Tingyu Wang, Wenyang Huang, Shuaishuai Zhang, Shuhua Yi, Yuting Yan, Tengteng Yu, Weiwei Sui, Gang An, Rui Lyu, Huimin Liu, Wenjie Xiong, Mingwei Fu, Dehui Zou, Lugui Qiu
Journal: Blood (2023)
Phase I First-in-Human Study on the Feasibility, Safety, and Antitumor Activity of CD4-Redirected Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with CD4+ T-Cell Malignancies (TCM)
Authors: Rita Assi, Nabil Hagag, Sherif Farag, Robert V.B. Emmons, Allie Carter, Magdalena Czader, Rafat Abonour, Lionel Apetoh, Yupo Ma, Huda S. Salman
Journal: Blood (2023)
Adherence to Clotting Factor Treatment and Association with Bleeding and Health-Related Quality of Life in Persons with Hemophilia
Authors: Duc Quang Tran Jr., Megan M. Ullman, Brenda Riske, Cathy Buranahirun-Burns, Amy D. Shapiro, Margaret V. Ragni, Barbara A. Konkle, Nicole Crook, Jonathan C. Roberts, Randall Curtis, Joanne Wu, Michael B. Nichol
Journal: Blood (2023)
Correlation of TCR Repertoire Diversity with Myeloid Gene Mutations in Chronic and Advanced Phase Myeloproliferative Neoplasms
Authors: Miguel Piris-Villaespesa, Juan Marquet, Val Fernandez-Lanza, Valentín García Gutiérrez, Carlos Jimenez, Francisco J del Castillo, Gloria Muñoz, Javier López
Journal: Blood (2023)
The Combination of Lanraplenib, a Selective SYK Inhibitor, and Gilteritinib, a FLT3 Inhibitor, Targets Aberrant Proliferation and Differentiation Blockade in Acute Myeloid Leukemia
Authors: Luis A. Carvajal, Michael R. McKeown, Tressa Hood, Linlin Guo, Charles Y. Lin, Jorge F. DiMartino
Journal: Blood (2023)
Impact of Baseline Comorbidities and Treatment on Cardiovascular (CV) Outcomes in Patients with Chronic Lymphocytic Leukemia (CLL): Results of a Systematic Literature Review (SLR) of Interventional Trials and a Targeted Literature Review (TLR) of Real-World Observational Studies in CLL
Authors: Yen-Chou Chen, Paulo Andre P. Palhares De Miranda, Bersabeh Sile, Grace Fox, Chinenye Chukwu, Javid J. Moslehi, Rupal O'Quinn
Journal: Blood (2023)
Safety of Elranatamab in Patients with Triple-Class Refractory Relapsed/Refractory Multiple Myeloma (RRMM) in Magnetismm-17, a North American Expanded Access Protocol
Authors: Nizar J Bahlis, Suzanne Trudel, Christopher Maisel, Lisa X. Lee, Jorge Monge, Claudia Paba Prada, Sarah M. Larson, Guenther Koehne, Yogesh Jethava, Wei Dong Ma, Cristina De Nicolo, Isabel Perez-Cruz
Journal: Blood (2023)
A Modified Busulfan/Cyclophosphamide Preconditioning Regimen Incorporating Selinexor for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hematologic Malignancies
Authors: Xiaofei Ni, Weihua Zhai, AiMing Pang, Donglin Yang, Xin Chen, Qiaoling MA, Jialin Wei, Yi He, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang
Journal: Blood (2023)
Targeting Myeloid Epithelial Tyrosine Kinase (MERTK) Receptor in Acute Myeloid Leukemia Using a Novel Antibody Drug Conjugate, Rgx-019-MMAE
Authors: Anudishi Tyagi, Maryam Siddiqui, Isabel Kurth, Shugaku Takeda, Amanda Eckstrom, Jenny Borgman, Abhishek Maiti, Venkata Lokesh Battula
Journal: Blood (2023)
Evaluating the Performance of Large Language Models in Hematopoietic Stem Cell Transplantation Decision Making
Authors: Ivan Civettini, Arianna Zappaterra, Daniele Ramazzotti, Bianca Maria Granelli, Giovanni Rindone, Andrea Aroldi, Stefano Bonfanti, Federica Colombo, Marilena Fedele, Giovanni Grillo, Matteo Parma, Paola Perfetti, Elisabetta Terruzzi, Carlo Gambacorti-Passerini, Fabrizio Cavalca
Journal: Blood (2023)
Results of an Open-Label Phase 1 Study Repurposing Oral Metformin and Nelfinavir in Combination with Subcutaneous Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma
Authors: Ibrahim Alodhaibi, Sikander Ailawadhi, Gaby E Perez Burbano, Patrick O'Brien, Francis Buadi, Suzanne R. Hayman, Shaji Kunnathu Kumar, Wilson I. Gonsalves
Journal: Blood (2023)
Efficacy and Safety of Daratumumab in Combination with Bortezomib, Thalidomide, and Dexamethasone Regimens in Newly Diagnosed Multiple Myeloma with Renal Insufficiency in Real-World: A Non-Interventional Prospective Multicenter Observational Study
Authors: Chengcheng Fu, Jing Wang, Lingzhi Yan, Song Jin, Jingjing Shang, Xiaolan Shi, Weiqin Yao, Zhi Yan, Mingqing Zhu, De-Pei Wu
Journal: Blood (2023)
The Final Results of a Phase I Study Using Bortezomib (Velcade), Cladribine, and Rituximab (VCR) in Treating Mantle Cell Lymphoma
Authors: Jeffrey J. Pu, Kristin Berger, Chunlei Zheng, Nhan V Do, David F. Claxton, W Christopher Ehmann, Joseph J. Drabick, Thomas P. Loughran, Elliot Epner
Journal: Blood (2023)
Single-Cell Analyses Unveil a Potential Mechanism Promoting Graft-Versus-Leukemia Response in Haploidentical Transplantation Using Peripheral Stem Cells Plus Cord Blood Grafts through Early Immune Reconstruction of CD8+ Infg+ T Cells
Authors: Sijian Yu, Qifa Liu, Xi Xu, Qiong Liu, Guo Qiu
Journal: Blood (2023)
Efficacy and Safety of Low-Dose Venetoclax Combined with Voriconazole Inpatients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy
Authors: Danchen Meng, Min Ruan, Xinyao Liu, Wei Wu, Junling Zhuang, Jian Ge, Zhenqi Huang, Zhangbiao Long
Journal: Blood (2023)
Ixazomib Maintenance Therapy in Chinese Patients with Newly Diagnosed Multiple Myeloma Not Treated with Stem Cell Transplantation: A Single-Arm, Open-Label Study
Authors: Weijun Fu, Juan Du, Lu Zhong, Lijuan Chen, Jian Li, Donghua Zhang, Jianqing Mi, Yan Liu, Sheng Wu, Richard Labotka, Cong Li, Wenhan Jiang, Wenming Chen
Journal: Blood (2023)
Graft-Versus-Host Disease (GvHD) and Steroid-Refractory GvHD after Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World EBMT-Based Epidemiology and Treatment Pattern Study
Authors: Selim Corbacioglu, Jarl Mooyaart, Emmanuelle Polge, William Boreland, Jessica Lemaitre, Christophe Peczynski, Anja van Biezen, Thomas Schroeder, Henrik Sengeloev, Daniele Avenoso, Peter Brossart, Eleni Gavriilaki, Maria Caterina Mico', Carmen Martínez, Manuel Jurado Chacón, Simona Sica, Stella Santarone, Stig Lenhoff, Marco Ladetto, Jose A. Pérez-Simón, Yves Beguin, Stefan Klein, Maria Jesús Pascual, Sibel Gunes, Catalin Bobirca, Olaf Penack, Zinaida Perić
Journal: Blood (2023)
Assessment of Incidence of Distress and Utilization of Supportive Care Services in Multiple Myeloma Patients, a Retrospective Single Center Experience
Authors: Hamid Ehsan, Myra Robinson, Patrick Meadors, Rushil Patel, Shanice Borden, Peter M. Voorhees, Delcan Walsh, Barry Paul, Manisha Bhutani, Cindy Varga, Shebli Atrash
Journal: Blood (2023)
Preclinical Efficacy of a Novel CD8-Targeted Fusosome for In Vivo CAR T Cell Therapy
Authors: Vandana Chaturvedi, Jesse Green, Garrett Zipp, Aaron Lampano, Ouwen Liang, Allison O'Rourke, Brian Granger, Kutlu G Elpek, Neal van Hoeven, Terry Fry
Journal: Blood (2023)
Autologous MPO Knock-out Hematopoietic Stem and Progenitor Cells for Pulmonary Arterial Hypertension
Authors: Aurélien BL Colamartino, Zulema Romero Garcia, Jenny Shapiro, Anat Kahana, Yeshai Schary, Leoni Gnatzy-Feik, Eva Berghausen, Mario Zierden, Stephan Rosenkranz, Donald B. Kohn
Journal: Blood (2023)
Multiple Myeloma Induced IL-6 Reprograms Lipid Metabolism through a CD36 Dependent Mechanism
Authors: Martha Ehikioya, Annalisa Altera, Katherine Hampton, Rebecca S Maynard, Dominic Fowler-Shorten, Charlotte Hellmich, Kristian Bowles, Matthew Markham, Ravindu De Silva, Stuart Rushworth
Journal: Blood (2023)
Outcomes after Bone Marrow Versus Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation
Authors: Joe S. Al-Ramahi, Moazzam Shahzad, Muhammad Kashif Amin, Shaun DeJarnette, Maggie Nelson, Forat Lutfi, Nausheen Ahmed, Haitham Abdelhakim, Rajat Bansal, Leyla Shune, Al-Ola Abdallah, Anurag K. Singh, Sunil Abhyankar, Joseph P McGuirk, Muhammad Umair Mushtaq
Journal: Blood (2023)
Iadademstat and Gilteritinib for the Treatment of FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia: The Frida Study
Authors: Amir T. Fathi, Theodore P Braun, Alexander Joseph Ambinder, Gautam Borthakur, Robert L. Redner, Mabel Arevalo, Sonia Gutierrez, Ana Limon, Douglas V. Faller
Journal: Blood (2023)
Blood Basophil Concentration at Diagnosis Corelates with Prognosis in Newly-Diagnosed Persons with Chronic Myeloid Leukaemia
Authors: Lucia Vrablova, Xiaoshuai Zhang, Eva Kriegova, Milos Kudelka, Martin Radvansky, Sen Yang, Jaroslava Juranova, Tomas Papajik, Robert Peter Gale, Qian Jiang, Edgar Faber
Journal: Blood (2023)
Risk Factors for Positive Posttransplantation Measurable Residual Disease in Patients with Acute Lymphoblastic Leukemia
Authors: Yuewen Wang, Guomei Fu, Lanping Xu, Yu Wang, Yi-Fei Cheng, Yuanyuan Zhang, Xiaohui Zhang, Yanrong Liu, Kaiyan Liu, Xiao-Jun Huang, Ying-Jun Chang
Journal: Blood (2023)
T Cell Ig and ITIM Domains (TIGIT) Expression in Multiple Myeloma
Authors: Ombretta Annibali, Monica Di Cecca, Martina Verri, Mariantonietta Tafuri, Antonella Bianchi, Paolo Schiaroli, Valeria Tomarchio, Anna Crescenzi, Giuseppe Avvisati, Luigi Rigacci
Journal: Blood (2023)
Significance of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Monocyte-to-Lymphocyte Ratio in the Prognosis of Newly Diagnosed Multiple Myeloma Patients
Authors: Kriti Mehra, Chidambaram Ramasamy, Navya Reddy Perkit, Abhishek Singh, Madhan Srinivasan Kumar, Kala Seetharaman
Journal: Blood (2023)
The Outcomes of Pregnancies in Japanese Patients with CML in the TKI Era; A Result of Nationwide Survey
Authors: Takeshi Kondo, Eri Matsuki, Tomoiku Takaku, Masaya Okada, Kazunori Murai, Chikashi Yoshida, Naoki Watanabe, Naoto Takahashi, Shinya Kimura, Itaru Matsumura
Journal: Blood (2023)
In Vivo Potency of Hematopoietic Stem Cells after Long-Term Storage at -80C in DMSO+HES Cryprotectant Mixture: Comparing Engraftment Kinetics and Efficacy Data in First and Second Autologous Stem Cell Transplantation in Myeloma
Authors: Joseph Norton, Loredana Campo, Patrick Hagen, Stephanie B. Tsai, Patrick J. Stiff
Journal: Blood (2023)
High Prevalence of <i>MYD88</i> and <i>CD79B</i> Mutations and <i>PD-L1</i> Alterations in Bone Marrow Large B Cell Lymphoma Associated with Hemophagocytic Lymphohistiocytosis
Authors: Wenyu Shi, Yi Miao, Yu Shi, Huayuan Zhu, Jianyong Li
Journal: Blood (2023)
Efficacy, Safety, and Survival Findings after Long-Term Follow-up from ZGJAK002, a Phase 2 Study Comparing Jaktinib 100 Mg Twice Daily with 200 Mg Once Daily for Myelofibrosis (MF)
Authors: Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huanling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jianda Hu, Yan Li, Yu Hu, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Shanshan Suo, Wenjuan Yu, Jie Jin
Journal: Blood (2023)
Real-World Use of Hypomethylating Agents (HMA)/Venetoclax Combinations in Patients with Myelodysplastic Neoplasms (MDS) in the Arabian Gulf Region
Authors: Fatima Khadadah, Honar Cherif, Halima El Omri, Ahmed Absi, Noor Merwass, Mohamed I. Abu Haleeqa, Waed Jaber, Ahmad Alhuraiji, Ramesh Pandita
Journal: Blood (2023)
The Role of High-Dose Regimens Followed By Autologous Stem Cell Transplantation for Salvage Chemotherapy-Sensitive DLBCL Patients
Authors: Mamiko Momoki, Atsushi Katsube, Masaharu Kawashima, Kazuhito Suzuki, Ryoko Fukushima, Tadahiro Gunji, Hiroto Ishii, Hideki Uryu, Kaichi Nishiwaki, Shingo Yano
Journal: Blood (2023)
The Impact of ZNF384 Rearranged on Antigen Editing during Treatment-Specific Selective Pressures in Adult B Cell Acute Lymphoid Leukemia
Authors: Runxia Gu, Wenbin Liu, Yihan Mei, Le Li, Chunlin Zhou, Yan Li, Yuntao Liu, Shuning Wei, Dong Lin, Kaiqi Liu, Qiuyun Fang, Xiaoyuan Gong, Benfa Gong, Shaowei Qiu, Bingcheng Liu, Yingchang Mi, Hui Wei, Ying Wang, Jianxiang Wang
Journal: Blood (2023)
<i>Circulating Cell-Free DNA (ccfDNA) Concentrations Measured By Capillary Electrophoresis: High Cost-Effectiveness in Discriminating DLBCL Patients and Associations with High Tumor Burden</i>
Authors: Luís Alberto de Pádua Covas Lage, Hebert Fabrício Culler, Cadiele Oliana Reichert, Karolinny Silva de Oliveira, Giselle Groetares de Lima, Fábio Alessandro de Freitas, Débora Levy, Renata de Oliveira Costa, Vanderson Rocha, Fernando Luiz Afonso Fonseca, Sarah Isabel P M do N Alves, Juliana Pereira
Journal: Blood (2023)
Real-World Data in a Prospective Clinical Observation Study for Newly Diagnosed Adult Acute Lymphoblastic Leukemia, the JALSG ALL-CS-12 : Advanced Age Is a Poor Prognostic Factor
Authors: Yoshihiro Hatta, Fumihiko Hayakawa, Etsuko Yamazaki, Tohru Murayama, Takeshi Saito, Satoru Takada, Nobuaki Dobashi, Shuichi Ota, Yasuhisa Yokoyama, Masatsugu Tanaka, Shinya Sato, Shigeki Ohtake, Emiko Sakaida, Yoshinobu Maeda, Takahiro Yamauchi, Itaru Matsumura, Yasushi Miyazaki, Hitoshi Kiyoi
Journal: Blood (2023)
A Novel and Potent EZH1/2 Dual Inhibitor, HM97662 Demonstrated a Wide Spectrum of Therapeutic Potential for Hematological Malignancies
Authors: Seung Hyun Jung, Jooyun Byun, Yu-Yon Kim, Seon Yeong Han, Miyoung Lee, Gunwoo Lee, Junghwa Park, Young Gil Ahn, Young Hoon Kim, Kwee Hyun Suh, Youngil Koh
Journal: Blood (2023)
The Reticulin, Collagen, Osteosclerosis (RCO) Score Is Clinically and Prognostically Relevant in Patients with Secondary Myelofibrosis (SMF)
Authors: Giacomo Coltro, Raffaella Santi, Alessandro Atanasio, Paolo Cicogna, Paola Guglielmelli, Umberto Gianelli, Alessandro M. Vannucchi
Journal: Blood (2023)